Enzo Life Sciences, Inc.
Records under this name other than the patents Enzo Life Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.
Back to Enzo Life Sciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,863,431 | Label Target and Labeling Reagents Comprising Rigid Group Backbones Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,969,525 | Hydroxycholesterol Immunoassay Formerly held In force · High confidence | In force | High confidence | |
| US 10,278,960 | Sphingosine Pathway Modulating Compounds for the Treatment of Cancers Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,675,255 | Sphingosine Pathway Modulating Compounds for the Treatment of Cancers Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,881,643 | Sphingosine Pathway Modulating Compounds for the Treatment of Cancers Formerly held In force · High confidence | In force | High confidence | |
| US 11,865,105 | Sphingosine Pathway Modulating Compounds for the Treatment of Cancers Formerly held In force · High confidence | In force | High confidence | |
| US 10,364,211 | Methods and Intermediates for Synthesizing SK1-I Formerly held In force · High confidence | In force | High confidence | |
| US 10,683,257 | Methods and Intermediates for Synthesizing SK1-I Formerly held In force · High confidence | In force | High confidence | |
| US 9,309,563 | Novel compositions and processes for analyte detection, quantification and amplification Formerly held Term ended Ended no later than Oct 22, 2026 · Low confidence | Term ended | Ended no later than Oct 22, 2026 | Low confidence |
| US 10,060,910 | Multisignal Reagents for Labeling Analytes Lapsed on the fee record Ended Aug 28, 2026 · Medium confidence | Lapsed on the fee record | Ended Aug 28, 2026 | Medium confidence |